» Mergers and acquisitions
Skadden, Latham handle $3.4B pharma deal
Latham & Watkins LLP represented Aliso Viejo-based drugmaker Avanir Pharmaceuticals Inc. in its $3.4 billion sale to Otsuka Pharmaceutical Co. Ltd. in a deal announced Dec. 2.
Avanir will continue to operate as an independent subsidiary of Otsuka America Inc. The two companies will partner in the U.S. for the development and commercializat...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In